http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CY-1112575-T1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_331acb2d2e4707f43b8f6c3cf6f79ab2
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-552
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-16063
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-16034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5252
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-24043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5254
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16734
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-13034
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-295
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-125
filingDate 2011-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69268dbf2ed8816db1166c199aa839d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd4da9791a356d357e8f036576eec7b6
publicationDate 2016-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CY-1112575-T1
titleOfInvention IMPROVED FCV VACCINATED VACCINES
abstract The present invention relates to improved inactivated feline calcium virus (FCV) vaccines. The invention also provides a process for the preparation of stabilized inactivated FCV, and the use of such stabilized inactivated FCV, in the production of immunogenic FCV compositions. The invention further provides methods of inducing an immune response in an animal of the feline family (Falidae), preferably in a cat, using the immunogenic compositions according to the invention.
priorityDate 2004-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559505
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460341

Total number of triples: 34.